ArQule, Inc. Logo

Email this page: News Release

ArQule and Daiichi Sankyo Announce Discontinuation of Phase 3 MARQUEE Clinical Trial in Non-Small Cell Lung Cancer

For security reasons, registration is required before you can use this feature.
* Indicates required field